Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Clarivate (CLVT) Shares Outstanding (Diluted Average) (2017 - 2025)

Clarivate (CLVT) has disclosed Shares Outstanding (Diluted Average) for 9 consecutive years, with $673.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) fell 2.93% year-over-year to $673.3 million, compared with a TTM value of $673.3 million through Dec 2025, down 2.93%, and an annual FY2025 reading of $673.3 million, down 2.93% over the prior year.
  • Shares Outstanding (Diluted Average) was $673.3 million for Q4 2025 at Clarivate, down from $679.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $693.6 million in Q4 2024 and bottomed at $612.6 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $669.9 million, with a median of $677.4 million recorded in 2022.
  • The sharpest move saw Shares Outstanding (Diluted Average) surged 74.49% in 2021, then dropped 2.93% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $640.8 million in 2021, then grew by 5.9% to $678.6 million in 2022, then fell by 1.03% to $671.6 million in 2023, then increased by 3.28% to $693.6 million in 2024, then fell by 2.93% to $673.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CLVT at $673.3 million in Q4 2025, $679.7 million in Q3 2025, and $685.5 million in Q2 2025.